Skip to content

Article: Mechanistic Insights into NAD+ Driven Activation of Phosphite Dehydrogenase: Preclinical Findings

Mechanistic Insights into NAD+ Driven Activation of Phosphite Dehydrogenase: Preclinical Findings


Synopsis

Research shows that the energy from the ADP part of the NAD+ molecule helps drive a shape change in phosphite dehydrogenase (PTDH), which activates the enzyme to transfer a hydride from phosphite to NAD+. The ADP fragment alone provides over 8.5 kcal/mol of stabilization to the transition state of this reaction. Both the ADP and AMP parts of NAD+ can also activate PTDH to transfer a hydride to nicotinamide riboside (NR), stabilizing the transition state by 5.1 and 2.7 kcal/mol, respectively, through interactions with the α- and β-phosphates. In contrast, the adenosine part of NAD+ does not stabilize the transition state. Activation appears to occur because a cation–anion interaction involving the K76 residue stabilizes the closed form of PTDH by bridging the α- and β-phosphates. Comparatively, other enzymes like formate dehydrogenase and glycerol phosphate dehydrogenase mainly rely on interactions with only the α-phosphate for activation. These findings indicate that different dehydrogenases have evolved diverse ways to use cofactor interactions to trigger the conformational changes needed for hydride transfer.

Journal

Biochemistry

Read more

Alzheimer's Disease

NAD+ Reverses Alzheimer’s Deficits: Preclinical Findings

Synopsis Alternative splicing defects are common features of aging and Alzheimer's disease (AD). This study identifies a previously unknown way that boosting NAD+ restores brain function: NAD+ hel...

Read more
Clinical

Nicotinamide Riboside Increases NAD+ Levels and Improves Symptom Recovery in Long COVID: Clinical Findings

Objectives To investigate the effects of NR supplementation on NAD+ levels, cognitive function, and long COVID symptoms in non-hospitalized individuals with long COVID.  Journal The Lancet eClinic...

Read more